Schedule 13D ownership disclosure

Disc Medicine Inc

Common Stock · CUSIP: 254604101

Event date: 2025-03-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ORBIMED ADVISORS LLCReported CIK 0001055951

    Shares: 1,556,369.00 · Class: 4.5%

  • ORBIMED CAPITAL GP VI LLCReported CIK 0001682115

    Shares: 530,487.00 · Class: 1.5%

  • OrbiMed Capital GP VIII LLCReported CIK 0001845804

    Shares: 820,707.00 · Class: 2.4%

  • OrbiMed Genesis GP LLCReported CIK 0001808744

    Shares: 205,175.00 · Class: 0.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-25-000305
Form type
SCHEDULE 13D/A
Filer
Disc Medicine, Inc.
CIK
CIK 1816736
Filed
Mar 12, 2025
Reporting period
Mar 10, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub